Skip to content

Mescaline: all studies

Page 44 of 97: studies 431 to 440 of 963, newest first. Back to the mescaline overview

Research

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis

Journal of Psychopharmacology May 1, 2007 Karsten Heekeren, Anna Neukirch, Jörg Daumann et al. 49 citations

Patients with schizophrenia exhibit diminished prepuLse inhibition (PPI) of the acoustic startle reflex and deficits in the attentional moduLation of PPI. Pharmacological challenges with hallucinogens are used as models for psychosis in both humans and animals. RemarkabLy, in contrast to the findings in schizophrenic patients and in animal hallucinogen modeLs of psychosis, previous studies with...

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

Addiction December 20, 2006 Robert S. Gable 240 citations

ABSTRACT Aim To extend previous reviews by assessing the acute systemic toxicity and psychological hazards of a dimethyltryptamine and β‐carboline brew (ayahuasca/hoasca) used in religious ceremonies. Method A systematic literature search, supplemented by interviews with ceremony participants. Results No laboratory animal models were located that tested the acute toxicity or the abuse potential...

Can psychedelics have a role in psychiatry once again?

The British Journal of Psychiatry June 1, 2005 Ben Sessa 97 citations

Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.

A Possible Case of Venlafaxine-Induced Stevens-Johnson Syndrome

The Journal of Clinical Psychiatry October 15, 2004 Nicholas Weiss, Lee Jones, John Chamberlain 33 citations

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Psychosis due to sleep deprivation has been frequently reported.1 In hallucinogen use, however, the duration of sleep deprivation is usually limited to a few days, and psychosis is attributed to the direct effects of the hallucinogens on the central nervous...

DOI: 10.4088/jcp.v65n1020d (opens in new tab) Mescaline Hallucinogen Psychosis Sleep deprivation +3

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

Therapeutic Drug Monitoring March 19, 2004 Hans H Maurer, Thomas Kræmer, Dietmar Springer et al. 147 citations

Designer drugs of the amphetamine type (eg, MDMA, MDEA, MDA), of the new benzyl or phenyl piperazine type (eg, BZP, MDBP, mCPP, TFMPP, MeOPP), or of the pyrrolidinophenone type (eg, PPP, MOPPP, MDPPP, MPPP, MPHP) have gained popularity and notoriety as rave drugs. These drugs produce feelings of euphoria and energy and a desire to socialize. Although in the corresponding drug scene designer...

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

Behavioural Pharmacology March 1, 2004 William E Fantegrossi, James H Woods, Gail Winger 99 citations

Relatively few studies have assessed the reinforcing effects of hallucinogenic compounds, and no such studies have attempted to engender contingent responding for these compounds in animals with behavioral histories that include experience with serotonergically mediated reinforcing effects. The objectives of the present study were to investigate the capacity of several hallucinogenic compounds...

Ocular sequelae from the illicit use of class A drugs

British and Irish Orthoptic Journal 2004 Alison Firth 13 citations

Aim: To highlight the changes that may take place in the visual system of the class A drug abuser.Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs. These include stimulants (cocaine and crack cocaine), narcotics (heroin, morphine, methadone) and hallucinogenics (ecstasy, lysergic acid diethylamide, magic mushrooms, mescaline,...

Designer Hallucinogens

Emergency Medicine News December 1, 2003 Leon Gussow

A 25-year-old man was brought to the emergency department from a late-night dance club. A friend reported that the patient commonly used designer drugs that he purchased over the Internet. While at the club, he started to vomit and experience visual hallucinations. He had no previous medical history and took no prescription medications. On searching the patient's clothing, medical staff found...

Brain mechanisms of hallucinogens and entactogens

Dialogues in Clinical Neuroscience December 31, 2001 Franz X. Vollenweider 127 citations

This review focuses on recent brain imaging and behavioral studies of sensory gating functions, which assess similarities between the effects of classic hallucinogens (eg, psilocybin), dissociative anesthetics (eg, ketamine), and entactogens (eg, 3,4-methylenedioxymethamphetamine [MDMA]) in humans. Serotonergic hallucinogens and psychotomimetic anesthetics produce overlapping psychotic...

Writing on drugs

Choice Reviews Online March 1, 2001 52 citations

Through a series of close, fascinating examinations of writing on drugs via, among others, Coleridge on opium, Freud on cocaine, Michaux on mescaline, and Burroughs on all of them, Writing on Drugs combines literary criticism with both socio-cultural history and pharmacological science to show how and why drugs have so thoroughly invaded modernity in ways precise and various, profound and...